These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24141897)

  • 1. Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.
    Fabian CJ; Kimler BF; Donnelly JE; Sullivan DK; Klemp JR; Petroff BK; Phillips TA; Metheny T; Aversman S; Yeh HW; Zalles CM; Mills GB; Hursting SD
    Breast Cancer Res Treat; 2013 Nov; 142(1):119-32. PubMed ID: 24141897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.
    Fabian CJ; Nye L; Powers KR; Nydegger JL; Kreutzjans AL; Phillips TA; Metheny T; Winblad O; Zalles CM; Hagan CR; Goodman ML; Gajewski BJ; Koestler DC; Chalise P; Kimler BF
    Cancer Prev Res (Phila); 2019 Oct; 12(10):711-720. PubMed ID: 31420361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo.
    Fabian CJ; Befort CA; Phillips TA; Nydegger JL; Kreutzjans AL; Powers KR; Metheny T; Klemp JR; Carlson SE; Sullivan DK; Zalles CM; Giles ED; Hursting SD; Hu J; Kimler BF
    Cancer Prev Res (Phila); 2021 Sep; 14(9):893-904. PubMed ID: 34244155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight loss reduces breast ductal fluid estrogens in obese postmenopausal women: a single arm intervention pilot study.
    Carpenter CL; Duvall K; Jardack P; Li L; Henning SM; Li Z; Heber D
    Nutr J; 2012 Dec; 11():102. PubMed ID: 23217221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between changes in fat distribution and biomarkers for breast cancer.
    van Gemert WA; Monninkhof EM; May AM; Elias SG; van der Palen J; Veldhuis W; Stapper M; Stellato RK; Schuit JA; Peeters PH
    Endocr Relat Cancer; 2017 Jun; 24(6):297-305. PubMed ID: 28512158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors.
    Thompson HJ; Sedlacek SM; Wolfe P; Paul D; Lakoski SG; Playdon MC; McGinley JN; Matthews SB
    Nutrients; 2015 Jun; 7(7):5156-76. PubMed ID: 26132992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese.
    Rock CL; Pande C; Flatt SW; Ying C; Pakiz B; Parker BA; Williams K; Bardwell WA; Heath DD; Nichols JF
    Clin Breast Cancer; 2013 Jun; 13(3):188-95. PubMed ID: 23375717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Weight Loss with or without Exercise on Inflammatory Markers and Adipokines in Postmenopausal Women: The SHAPE-2 Trial, A Randomized Controlled Trial.
    van Gemert WA; May AM; Schuit AJ; Oosterhof BY; Peeters PH; Monninkhof EM
    Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):799-806. PubMed ID: 26908432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.
    Fabian CJ; Kimler BF; Phillips TA; Nydegger JL; Kreutzjans AL; Carlson SE; Hidaka BH; Metheny T; Zalles CM; Mills GB; Powers KR; Sullivan DK; Petroff BK; Hensing WL; Fridley BL; Hursting SD
    Cancer Prev Res (Phila); 2015 Oct; 8(10):922-31. PubMed ID: 26276744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Weight Loss and Weight Regain on Circulating Biomarkers in Overweight/Obese Breast Cancer Survivors Enrolled in a Weight Loss Trial in the Rural Midwest.
    Befort CA; Kimler BF; Bantis LE; Phillips TA; Fabian CJ
    Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1321-1328. PubMed ID: 32277008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study.
    Bayraktar S; Baghaki S; Wu J; Liu DD; Gutierrez-Barrera AM; Bevers TB; Valero V; Sneige N; Arun BK
    Cancer Prev Res (Phila); 2020 Sep; 13(9):795-802. PubMed ID: 32513785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients ('CHOICE'): study protocol.
    Sedlacek SM; Playdon MC; Wolfe P; McGinley JN; Wisthoff MR; Daeninck EA; Jiang W; Zhu Z; Thompson HJ
    BMC Cancer; 2011 Jul; 11():287. PubMed ID: 21733177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women.
    Friedenreich CM; Neilson HK; Woolcott CG; McTiernan A; Wang Q; Ballard-Barbash R; Jones CA; Stanczyk FZ; Brant RF; Yasui Y; Irwin ML; Campbell KL; McNeely ML; Karvinen KH; Courneya KS
    Endocr Relat Cancer; 2011 Jun; 18(3):357-69. PubMed ID: 21482635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
    Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
    BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.
    Fabian CJ; Kimler BF; Zalles CM; Klemp JR; Petroff BK; Khan QJ; Sharma P; Setchell KD; Zhao X; Phillips TA; Metheny T; Hughes JR; Yeh HW; Johnson KA
    Cancer Prev Res (Phila); 2010 Oct; 3(10):1342-50. PubMed ID: 20724470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
    Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
    Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tomato and soy on serum adipokine concentrations in postmenopausal women at increased breast cancer risk: a cross-over dietary intervention trial.
    Llanos AA; Peng J; Pennell ML; Krok JL; Vitolins MZ; Degraffinreid CR; Paskett ED
    J Clin Endocrinol Metab; 2014 Feb; 99(2):625-32. PubMed ID: 24423335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: the SHAPE-2 trial.
    van Gemert WA; Schuit AJ; van der Palen J; May AM; Iestra JA; Wittink H; Peeters PH; Monninkhof EM
    Breast Cancer Res; 2015 Sep; 17(1):120. PubMed ID: 26330303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women.
    Ryan AS; Nicklas BJ; Berman DM; Elahi D
    Int J Obes Relat Metab Disord; 2003 Sep; 27(9):1066-71. PubMed ID: 12917712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
    Khan QJ; Kimler BF; O'Dea AP; Zalles CM; Sharma P; Fabian CJ
    Breast Cancer Res; 2007; 9(3):R35. PubMed ID: 17537236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.